Veterinary Medicine Information website

GALLIMUNE 302 ND+IB+EDS Water-in oil emulsion for injection

Not authorised
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Ulster 2C, Inactivated
Download as PDF

Product identification

Medicine name:
GALLIMUNE 302 ND+IB+EDS Water-in oil emulsion for injection
Active substance:
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Ulster 2C, Inactivated
Target species:
  • Chicken (for reproduction)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
    162.00
    log10 haemagglutination inhibiting unit(s)
    /
    0.30
    millilitre(s)
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    10.00
    log10 haemagglutination inhibiting unit(s)
    /
    0.30
    millilitre(s)
  • Newcastle disease virus, strain Ulster 2C, Inactivated
    10.00
    log10 haemagglutination inhibiting unit(s)
    /
    0.30
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (for reproduction)
      • Egg
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Poland
Package description:
  • (ID2): 1 Box with 10 Bottle (PolyPropylene) with 150 millilitre(s) (1500 millilitre(s))
  • (ID1): 1 Box with 1 Bottle (PolyPropylene) with 150 millilitre(s) (150 millilitre(s))
  • (ID3): 1 Box with 1 Bottle (PolyPropylene) with 300 millilitre(s) (300 millilitre(s))
  • (ID4): 1 Box with 10 Bottle (PolyPropylene) with 300 millilitre(s) (3000 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1602
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0227/001